Minkui Luo
Minkui Luo is a prominent scientist known for his contributions to the field of biochemistry and molecular biology. He is particularly recognized for his research on epigenetics and enzyme mechanisms.
Early Life and Education[edit | edit source]
Minkui Luo was born in China. He pursued his undergraduate studies in chemistry at Peking University, where he developed a strong foundation in the chemical sciences. He later moved to the United States to continue his education, earning a Ph.D. in biochemistry from Harvard University.
Career[edit | edit source]
After completing his doctoral studies, Luo joined the faculty at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City. At MSKCC, he established a research laboratory focused on understanding the biochemical mechanisms underlying epigenetic regulation. His work has significant implications for the development of new therapeutic strategies for cancer and other diseases.
Research Contributions[edit | edit source]
Luo's research primarily revolves around the study of histone modifications and the enzymes that regulate these processes. He has made significant discoveries in the field of histone methylation and acetylation, elucidating how these modifications influence gene expression and chromatin structure.
One of his notable achievements includes the identification of novel histone demethylase enzymes, which play a crucial role in the dynamic regulation of histone methylation marks. His work has provided insights into the molecular basis of epigenetic memory and its implications for cell differentiation and development.
Awards and Honors[edit | edit source]
Throughout his career, Minkui Luo has received numerous awards and honors for his contributions to science. These include the American Chemical Society's Arthur C. Cope Scholar Award and the National Institutes of Health's Director's Pioneer Award.
Personal Life[edit | edit source]
Luo is known for his dedication to mentoring young scientists and fostering a collaborative research environment. He is also an advocate for increasing diversity in the scientific community.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD